203 related articles for article (PubMed ID: 11762154)
1. Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline.
Elliott JP; Bergauer NK; Jacques DL; Coleman SK; Stanziano GJ
J Reprod Med; 2001 Nov; 46(11):975-82. PubMed ID: 11762154
[TBL] [Abstract][Full Text] [Related]
2. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor.
Lam F; Istwan NB; Jacques D; Coleman SK; Stanziano GJ
Manag Care; 2003 Jul; 12(7):39-46. PubMed ID: 12891954
[TBL] [Abstract][Full Text] [Related]
3. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
4. A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations.
Lam F; Bergauer NK; Coleman SK; Stanziano GJ; Jacques D
J Perinatol; 2000; 20(7):408-13. PubMed ID: 11076323
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
Wenstrom KD; Weiner CP; Merrill D; Niebyl J
Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and economic outcomes in patients treated for recurrent preterm labor.
Fleming A; Bonebrake R; Istwan N; Rhea D; Coleman S; Stanziano G
J Perinatol; 2004 Apr; 24(4):223-7. PubMed ID: 14999214
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.
Laohapojanart N; Soorapan S; Wacharaprechanont T; Ratanajamit C
J Med Assoc Thai; 2007 Nov; 90(11):2461-9. PubMed ID: 18181335
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic outcomes of preterm labor management: inpatient vs outpatient.
Ambrose S; Rhea DJ; Istwan NB; Collins A; Stanziano G
J Perinatol; 2004 Aug; 24(8):515-9. PubMed ID: 15141268
[TBL] [Abstract][Full Text] [Related]
9. Tocolytic treatment for preterm contractions with and without cervical changes.
Brown HL; Hiett AK; Britton KA; Turnquest MA; Golichowski AM
Am J Perinatol; 1997 Aug; 14(7):405-9. PubMed ID: 9263560
[TBL] [Abstract][Full Text] [Related]
10. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy.
Elliott JP; Istwan NB; Rhea D; Stanziano G
Am J Obstet Gynecol; 2004 Oct; 191(4):1277-82. PubMed ID: 15507953
[TBL] [Abstract][Full Text] [Related]
11. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump.
Allbert JR; Johnson C; Roberts WE; Martin RW; Gookin KS; Morrison JC
J Reprod Med; 1994 Aug; 39(8):614-8. PubMed ID: 7996525
[TBL] [Abstract][Full Text] [Related]
12. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.
Jones JS; Morrison J; Istwan N; Rhea D; Collins A; Stanziano G
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):331-5. PubMed ID: 16801308
[TBL] [Abstract][Full Text] [Related]
13. Tocolytic therapy and clinical experience. Combination therapy.
Ingemarsson I
BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
[TBL] [Abstract][Full Text] [Related]
14. Terbutaline pump tocolysis in high-order multiple gestation.
Elliott JP; Flynn MJ; Kaemmerer EL; Radin TG
J Reprod Med; 1997 Nov; 42(11):687-94. PubMed ID: 9408866
[TBL] [Abstract][Full Text] [Related]
15. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations.
Lam F; Bergauer NK; Jacques D; Coleman SK; Stanziano GJ
J Perinatol; 2001; 21(7):444-50. PubMed ID: 11894512
[TBL] [Abstract][Full Text] [Related]
16. [Continuous subcutaneous administration of terbutaline in the therapy of threatening premature labour].
Pomini F; De Carolis S; Ferrazzani S; De Santis L; Carducci B; Caruso A
Minerva Ginecol; 1993; 45(1-2):57-63. PubMed ID: 8469366
[TBL] [Abstract][Full Text] [Related]
17. Use of the subcutaneous terbutaline pump for long-term tocolysis.
Lam F; Gill P; Smith M; Kitzmiller JL; Katz M
Obstet Gynecol; 1988 Nov; 72(5):810-3. PubMed ID: 3173932
[TBL] [Abstract][Full Text] [Related]
18. An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor.
Flick AA; de la Torre L; Roca LE; Istwan N; Rhea D; Desch C; González-Quintero VH
Am J Perinatol; 2010 Jan; 27(1):53-9. PubMed ID: 19823965
[TBL] [Abstract][Full Text] [Related]
19. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
European Atosiban Study Group
Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of terbutaline and magnesium sulfate in the management of preterm labor.
Surichamorn P
J Med Assoc Thai; 2001 Jan; 84(1):98-104. PubMed ID: 11281506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
